Multiple immune cell subsets

Multiple immune cell subsets refers to the diverse array of leukocyte populations, including T lymphocytes, B lymphocytes, natural killer (NK) cells, and myeloid-derived cells, which collectively coordinate the host immune response (NIH, 2023). This term is not a specific molecular target but rather a descriptive category used to characterize the broad cellular impact of immunomodulatory or immunosuppressive therapies (Nature Reviews Immunology, 2018). In clinical and pharmacological research, drugs such as corticosteroids or checkpoint inhibitors are often evaluated for their ability to simultaneously influence the activity, recruitment, or exhaustion states of these various cell populations (PubMed, 2021). Because the term encompasses multiple distinct biological entities with unique signaling pathways, it lacks the specificity required for a canonical molecular target definition. Consequently, it is typically used in the context of pharmacodynamic monitoring or systemic immune profiling rather than as a singular point of therapeutic intervention (Journal of Clinical Investigation, 2019). Understanding the collective behavior of these subsets is essential for managing complex diseases like cancer and systemic autoimmunity, where multi-cellular interactions drive pathogenesis (Science, 2022).

Other names

Immune cell populationsLeukocyte subsetsPeripheral blood mononuclear cellsImmune cell lineages

Broad modulation of immune signaling, proliferation, and effector functions across various leukocyte lineages.